- Home
- ESTA
as 07-26-2024 4:00pm EST
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
| Founded: | 2004 | Country: | Costa Rica |
| Employees: | N/A | City: | ALAJUELA |
| Market Cap: | 1.3B | IPO Year: | 2018 |
| Target Price: | $55.00 | AVG Volume (30 days): | 282.0K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.96 - $73.00 | Next Earning Date: | 08-06-2024 |
| Revenue: | $155,794,000 | Revenue Growth: | -8.23% |
| Revenue Growth (this year): | 11.44% | Revenue Growth (next year): | 34.84% |
Stock Insider Trading Activity of Establishment Labs Holdings Inc. (ESTA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chacon Quiros Juan Jose | ESTA | Chief Executive Officer | Jul 11 '24 | Sell | $45.04 | 3,641 | $163,989.18 | 210,735 | SEC Form 4 |
| Chacon Quiros Juan Jose | ESTA | Chief Executive Officer | Jul 8 '24 | Sell | $45.00 | 654 | $29,430.52 | 214,376 | SEC Form 4 |
| Chacon Quiros Juan Jose | ESTA | Chief Executive Officer | Jul 8 '24 | Sell | $45.01 | 3,866 | $174,011.75 | 215,030 | SEC Form 4 |
| Chacon Quiros Juan Jose | ESTA | Chief Executive Officer | Jul 1 '24 | Sell | $45.30 | 6,839 | $309,775.24 | 218,896 | SEC Form 4 |
| LEWIN NICHOLAS SHERIDAN | ESTA | Director | Dec 14 '23 | Buy | $26.96 | 231 | $6,226.61 | 1,063,119 | SEC Form 4 |
| LEWIN NICHOLAS SHERIDAN | ESTA | Director | Dec 14 '23 | Buy | $27.05 | 1,769 | $47,846.14 | 1,064,888 | SEC Form 4 |
| LEWIN NICHOLAS SHERIDAN | ESTA | Director | Nov 20 '23 | Buy | $22.00 | 5,000 | $110,000.00 | 14,190 | SEC Form 4 |
Latest Establishment Labs Holdings Inc. News
ESTA Breaking Stock News: Dive into ESTA Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
Simply Wall St.
3 days ago
Investors bid Establishment Labs Holdings (NASDAQ:ESTA) up US$50m despite increasing losses YoY, taking five-year CAGR to 13%
MT Newswires
10 days ago
Establishment Labs Reports Delay in FDA Preapproval Inspection of Motiva Implants Facility; Shares Fall After Hours
MT Newswires
23 days ago
Establishment Labs Holdings Insider Sold Shares Worth $309,775, According to a Recent SEC Filing
Simply Wall St.
24 days ago
Unveiling Three US Growth Companies With High Insider Ownership
Simply Wall St.
25 days ago
What Does Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Share Price Indicate?
Zacks
a month ago
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
MT Newswires
2 months ago
Mizuho Securities Raises Price Target on Establishment Labs to $70 From $65, Maintains Buy Rating
Compare ESTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ESTA Establishment Labs Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.